September 7, 2017 8:00 am JST

Rise in diabetes in Asia fuels demand for tests

Greater need for diagnostics in India, Southeast Asia along with prosperity

CMIC technicians conduct urinalysis testing in Vietnam.

TOKYO -- Japanese manufacturers of diagnostic tests for diabetes and other illnesses are ramping up operations in the rest of Asia, as they hope to catch up with global players by tapping into emerging markets.

In Southeast Asia, CMIC Holdings is launching a diabetes diagnostics business geared toward the affluent. The company recently received regulatory approval for its diabetes tests in the Philippines and Vietnam. CMIC will offer a service that can predict kidney disease, based on artificial intelligence that analyzes data collected at hospitals using its tests.

As incomes rise in emerging nations, so are the number of diabetes patients. In Vietnam alone, there are an estimated 2 million diabetics. Hospitals often struggle to keep up with the growing number of patients due to limited types of tests as well as a shortage of technicians to operate equipment. CMIC believes that treatment efficiency could be improved by narrowing its focus on potential patients.

Konoike Transport, meanwhile, is partnering with Tokyo-based J-VPD to launch a clinical testing business in India. Konoike will fly blood and tissue samples of patients to Japan, where partner companies will test for more than 1,000 indicators, including tumor markers. Results are delivered in about three days.

The partners will also train laboratory technicians in India and offer trainees opportunities to study in Japan.

According to Fuji Keizai, a Tokyo-based research firm, the global market for clinical laboratory testing is estimated to grow by 13% from 2015 figures to $70.4 billion in 2020. Asian markets outside of Japan are expected to drive the market's growth, as developed nations will mainly see replacement demand.

Meanwhile, the global market is dominated by such major players as Switzerland's F. Hoffmann-La Roche and U.S.-based Abbott Laboratories. Japanese companies aim to catch up to them by unearthing new demand. 

(Nikkei)

CMIC Holdings Co., Ltd.

Japan

Market(Ticker): TKS(2309)
Sector:
Industry:
Health Services
Services to the Health Industry
Market cap(USD): 278.91M
Shares: 18.92M

Konoike Transport Co., Ltd.

Japan

Market(Ticker): TKS(9025)
Sector:
Industry:
Transportation
Other Transportation
Market cap(USD): 919.89M
Shares: 56.93M

Get Insights on Asia In Your Inbox

To read the full story, Subscribe or Log in

Get your first month for $0.99

Redeemable only through the Subscribe button below

Once subscribed, you can…

  • Read all stories with unlimited access
  • Use our smartphone and tablet apps

To read the full story, Subscribe or Log in

3 months for $9
SUBSCRIBE TODAY

Take advantage of this limited offer.
Subscribe now to get unlimited access to all articles.

To read the full story, Update your account

Resubscribe now to continue reading.
BEST OFFER:
Only US$ 9.99 per month for a full-year subscription

To read the full story, Subscribe or Log in

Once subscribed, you can…

  • Read all stories with unlimited access
  • Use our smartphone and tablet apps

To read the full story, Subscribe or Log in

3 months for $9
SUBSCRIBE TODAY

Take advantage of this limited offer.
Subscribe now to get unlimited access to all articles.

To read the full story, Update your account

We could not renew your subscription.
You need to update your payment information.